Veterinary Medicines

Vigophos 100 mg / ml + 0.05 mg / ml solution for injection for cattle

Authorised
  • Cyanocobalamin
  • Butafosfan
Download as PDF

Product identification

Medicine name:
Vigophos 100 mg / ml + 0.05 mg / ml solution for injection for cattle
Vigophos, 100mg/ml, Injekční roztok
Active substance:
  • Cyanocobalamin
  • Butafosfan
Target species:
  • Cattle
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Cyanocobalamin
    0.05
    milligram(s)
    /
    1.00
    millilitre(s)
  • Butafosfan
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12CX91
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Available in:
  • Czechia
Package description:
  • Carton containing 12 Type II amber glass vials of 100 ml closed with a coated bromobutyl or chlorobutyl rubber stopper and sealed with an aluminium cap
  • Carton containing 6 Type II amber glass vial of 100 ml closed with a coated bromobutyl or chlorobutyl rubber stopper and sealed with an aluminium cap
  • Carton containing 1 Type II amber glass vial of 100 ml closed with a coated bromobutyl or chlorobutyl rubber stopper and sealed with an aluminium cap

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Livisto Int'l S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Animedica GmbH
  • Industrial Veterinaria S.A.
  • Animedica Herstellungs GmbH
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 96/016/18-C
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0426/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Germany
  • Hungary
  • Ireland
  • Italy
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 15/02/2022
Download
Czech (PDF)
Published on: 25/10/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 25/10/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 25/10/2022
Download

Combined File of all Documents

English (PDF)
Published on: 22/02/2024
Download

PuAR updated.pdf

English (PDF)
Published on: 26/02/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."